2-Oxo-pyrrolidine-3-carboxylic acid ethyl ester, 96.0%, 25g

Ethanesulfonamide, N-[4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]-, 98%, 50mg

(R)-tert-butyl 8-(3,5-difluorophenyl)-9-(2-ethoxy-2-oxoethyl)-10-oxo-6,9-diazaspiro[4.5]decane-6-carboxylate, 98%, 100mg

Boron Trifluoride - Ethyl Ether Complex>98.0%(W)25mL

(2E)-1-(2,5-dimethoxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

((4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)methyl)triphenylphosphonium bromide, 97%, 100g

4-benzyl-1-[(oxiran-2-yl)methyl]piperidine, 95.0%, 2g

(R)-1-(5-methylfuran-2-yl)ethanamine hydrochloride, 97+%, 100mg

2-Bromo-6-ethoxypyridine, 95.0%, 5g

2-Amino-10H-dibenzo[b,f][1,4]oxazepin-11-one, 1g

Methyl 2-(2-aminothiazol-5-yl)acetate, 97%, 250mg

Acetyl bromide, >97.0%(T), 500g

5-Chloro-2-pyridinecarboxylic Acid>98.0%(GC)(T)1g